Photo: Eugene biyatov / RIA Novosti
Brazilian clinic “albert Einstein” developed the world’s first genetic test for determination of coronavirus. It is reported TASS with reference to the portal G1.
According to him, high-precision analysis was patented in the U.S. in the international patent system world organization for intellectual property (PCT). From June it will be available for the diagnosis of coronavirus.
The basis for the development of scientists formed the technology of new-generation sequencing to analyze small DNA fragments to determine the disease. To recognize SARS-CoV-2 researchers have adapted this method for work with RNA that is present in viruses of different types.
The developers have stated that the accuracy of the test is 100 percent, and eliminates the possibility of false positive results. At the same time its efficiency is comparable to PCR tests that are now used for the detection of coronavirus.
In addition, this is the first genetic test that can be used for mass diagnostics because it can be used to simultaneously investigate 1536 samples, which is 16 times more than in PCR testing. As biomaterial is possible to take saliva or nasopharyngeal secret. The results of the study appear in three days.
Previously, scientists from Singapore have developed a rapid test that allows in one hour to determine the presence of antibodies to coronavirus in humans. The test also helps to assess what proportion of the population was already infected with the virus and recovered, and how the government is ready for gradual withdrawal from the strict quarantine measures.
Since the beginning of the pandemic coronavirus in the world has infected more than 5.1 million people, more than 332 thousand died. Russia was 317 554 cases of infection, recovered 92 681 people died 3 099.
Video, photo All from Russia.